| abstract |
By orally ingesting the basic protein derived from milk, production | generation of RANKL can be suppressed. RANKL production inhibitor comprising the milk-derived basic protein fraction as an active ingredient, a therapeutic agent for bone metabolism disease containing the RANKL production inhibitor and a therapeutic agent for immune diseases, and further, a RANKL production inhibitor comprising a specific amount of the RANKL production inhibitor, Foods and feeds have a remarkable effect of inhibiting the production of RANKL, can be consumed routinely, and have high safety even if consumed for a long time. |